<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01563991</url>
  </required_header>
  <id_info>
    <org_study_id>07-016</org_study_id>
    <nct_id>NCT01563991</nct_id>
  </id_info>
  <brief_title>Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes</brief_title>
  <official_title>Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes Following Elective Open Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subjects undergoing surgery on the small or large bowel will be randomized to one of 2&#xD;
      groups, a normal fluid amount group and a reduced fluid amount group to evaluate the impact&#xD;
      of this change on recovery after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the impact of reduction in the amount of&#xD;
      perioperative fluids on postoperative morbidity, postoperative recovery and the duration of&#xD;
      hospitalization. The study will accrue patients undergoing elective open intestinal resection&#xD;
      for benign and malignant conditions of the small and large bowel. Patients, who consent to&#xD;
      the study, will be randomized at the time of consent, preoperatively. The primary study&#xD;
      endpoint will a composite of mortality and major morbidity within the first 30 postoperative&#xD;
      days. Secondary endpoints will be return to bowel function (flatus or bowel movement),&#xD;
      postoperative hospital stay including the day of surgery and a composite of minor&#xD;
      complications. Approximately 186 patients will participate in the study, 93 in each group.&#xD;
      Patients will be randomized into one of two groups: the Restricted Fluid Regimen group and&#xD;
      the Normal Fluid Administration Regimen group. A very specific flow chart for each group will&#xD;
      be followed to distinguish the group. A research nurse will collect the data needed for the&#xD;
      study on a daily basis. The patient will be managed by the primary surgeon and his team and&#xD;
      the study group flow chart will be followed. If for medical reasons, the patient's care needs&#xD;
      to be varied from the study, this is allowed, and will be documented for the study purposes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">April 18, 2012</completion_date>
  <primary_completion_date type="Actual">April 18, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>5-7 days</time_frame>
    <description>Reduction in post-operative complications at the time of hospital discharge after the surgical episode</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">186</enrollment>
  <condition>Benign Neoplasm of Intestinal Tract</condition>
  <condition>Primary Malignant Neoplasm of Intestinal Tract</condition>
  <condition>Secondary Malignant Neoplasm of Intestinal Tract</condition>
  <arm_group>
    <arm_group_label>Standard fluid volume</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject receives normal fluid volume during peri-operative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reduced Fluid Volume</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject receives a reduced fluid volume during the peri-operative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normal fluid volume</intervention_name>
    <description>Normal fluid group will receive lactated ringes at 8 cc / Kg/ hr total</description>
    <arm_group_label>Standard fluid volume</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reduced fluid volume</intervention_name>
    <description>Subject receives 80 cc/ hr LR during the peri-operative period</description>
    <arm_group_label>Reduced Fluid Volume</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years or older&#xD;
&#xD;
          -  ASA I-III&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Creatinine less than or equal to 1.3 mg/mL)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients younger than 18 years old&#xD;
&#xD;
          -  ASA IV or higher&#xD;
&#xD;
          -  Urgent or emergent surgery&#xD;
&#xD;
          -  Mental disease or addictive disorders impairing ability to provide informed consent&#xD;
&#xD;
          -  Renal insufficiency (Cr greater than 1.3 mg/mL)&#xD;
&#xD;
          -  Significant language barriers&#xD;
&#xD;
          -  Cirrhosis causing ascites&#xD;
&#xD;
          -  NYHA III or IV, EF less than 25%&#xD;
&#xD;
          -  Use of intraoperative epidural anesthesia&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Uncontrolled hypertension in the opinion of the enrolling surgeon&#xD;
&#xD;
          -  ETOH consumption greater than 35 drinks weekly&#xD;
&#xD;
          -  Cachexia or absolute neutrophil count of less than 1,200/mm3&#xD;
&#xD;
          -  Existing uncontrolled coagulopathy or platelet count of less than 100,000/mm3&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucci Stocchi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <study_first_submitted>March 24, 2012</study_first_submitted>
  <study_first_submitted_qc>March 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2012</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Luca Stocchi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>surgery</keyword>
  <keyword>fluid</keyword>
  <keyword>morbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Intestinal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

